Bloomberg: Alaska Cites Court Ruling In Refusing Federal Health-Care Cash The Republican’s decision means the condition will skip today’s deadline to apply for a grant that federal government officials say is required to develop exchanges where occupants would be able to buy medical insurance beneath the new health-care law. THE INDIVIDUAL Protection and Affordable Treatment Work signed by Obama in March needs citizens over 18 to acquire health coverage beginning in 2014.ChemGenex utilizes proprietary chemical genomics and medication screening systems to identify agents affecting novel targets. Greg Collier, Chief Executive Officer of AGT Biosciences. Collier shall be CEO of the combined business. Dennis Dark brown, President and CEO of ChemGenex Therapeutics. Dr. Brown offers over 25 years of knowledge in applied cancer study and was previously a co-founder of Matrix Pharmaceutical, Inc. . Brown will be President of the combined company. Conditions of the Merger Agreement Under the terms of the merger contract, AGT Biosciences, with main shareholders Charter Pacific Corporation Merck-Sante , Queensland Investment Company , will acquire all the issued shares of ChemGenex Therapeutics through the issuance of around 28 million common shares of AGT Biosciences to the shareholders of ChemGenex Therapeutics.